stoxline Quote Chart Rank Option Currency Glossary
Guardion Health Sciences, Inc. (GHSI)
5.93  0 (0%)    12-01 11:25
Open: 6.21
High: 6.21
Volume: 831
Pre. Close: 5.93
Low: 5.93
Market Cap: 8(M)
Technical analysis
2023-12-01 4:20:13 PM
Short term     
Mid term     
Targets 6-month :  7.56 1-year :  8.83
Resists First :  6.47 Second :  7.56
Pivot price 5.72
Supports First :  5.68 Second :  5.19
MAs MA(5) :  5.91 MA(20) :  5.82
MA(100) :  7.05 MA(250) :  6.85
MACD MACD :  -0.2 Signal :  -0.3
%K %D K(14,3) :  61.7 D(3) :  58.6
RSI RSI(14): 48.1
52-week High :  10.5 Low :  4.65
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GHSI ] has closed below upper band by 28.5%. Bollinger Bands are 0.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.22 - 6.25 6.25 - 6.27
Low: 5.86 - 5.89 5.89 - 5.92
Close: 5.88 - 5.93 5.93 - 5.98
Company Description

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Headline News

Mon, 13 Nov 2023
Guardion Health Sciences Announces Financial Results for the ... - Yahoo Finance

Fri, 07 Jul 2023
Pre-market Movers: PWM, GRRR, ABL, HCTI, EDTX… - Nasdaq

Tue, 30 May 2023
Guardion Health Sciences Announces Appointment of Former ... - GlobeNewswire

Thu, 04 May 2023
Neptune Wellness to acquire ownership in baby food brand, Sprout ... - Seeking Alpha

Mon, 13 Feb 2023
Sientra Tries for New Look to Please Wall Street - Orange County Business Journal

Fri, 06 Jan 2023
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock ... - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers—Specialty & Generic
Shares Out 1 (M)
Shares Float 1 (M)
Held by Insiders 22.5 (%)
Held by Institutions 4 (%)
Shares Short 113 (K)
Shares Short P.Month 115 (K)
Stock Financials
EPS -12.1
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 6.03
Profit Margin -105.7 %
Operating Margin -23.2 %
Return on Assets (ttm) -13.8 %
Return on Equity (ttm) -74.5 %
Qtrly Rev. Growth 25.2 %
Gross Profit (p.s.) 3.53
Sales Per Share 9.4
EBITDA (p.s.) -3.3
Qtrly Earnings Growth 0 %
Operating Cash Flow -4 (M)
Levered Free Cash Flow -3 (M)
Stock Valuations
PE Ratio -0.5
PEG Ratio 0
Price to Book value 0.98
Price to Sales 0.63
Price to Cash Flow -1.72
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android